COMMUNIQUÉS West-GlobeNewswire

The Joint Corp. Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
- Increases Annual System-Wide Gross Sales 30%, Compared to 2017 - - Achieves Positive Annual Net Income for the First Time of $253,000 - - Sells 99 Franchise Licenses in 2018, Up from 37 in 2017 - SCOTTSDALE, Ariz., [...]
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
Provides Full Year 2019 Financial Outlook SANTA CLARA, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company that pioneered the minimally invasive surgical treatment of the [...]
MRI Interventions Announces Agreement with Siemens Healthineers For Interfacing with the Portfolio of Magnetom MRI Scanners
07/03/2019
Agreement Enables the Development of More Efficient Clinical Workflows, Advanced Functionality and Shorter Surgical Procedure Times In the MRI Suite IRVINE, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, [...]
Alphatec Spine Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
Secures Additional $30M Financing Commitment from Squadron Capital CARLSBAD, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), today announced financial results [...]
Harpoon Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
Webcast and Conference Call to be Held at 4:30 p.m. ET on March 14, 2019 SOUTH SAN FRANCISCO, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company [...]
Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights
07/03/2019
On Track to Dose First Patient in Pivotal Phase 3 Trial of Pegzilarginase for ARG1-D in Q2 of 2019 Initiated IND-Enabling Studies for New Pipeline Programs Progress with Pegzilarginase Cancer Indication-Phase 2 [...]
Aravive Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Recent Corporate Updates
07/03/2019
HOUSTON, March 07, 2019 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company focused on developing innovative therapies that target important survival pathways for cancer, [...]
Profound Medical Announces Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
TORONTO, March 07, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Chembio Diagnostics Awarded UNICEF Contract to Supply Point-of-Care Zika/Chikungunya/Dengue Tests and Micro Readers
07/03/2019
MEDFORD, N.Y., March 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today announced that it will be awarded a conditional Long [...]
La Jolla Pharmaceutical Company to Present at the 39th Annual Cowen Healthcare Conference
07/03/2019
SAN DIEGO, March 07, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
ChromaDex Corporation Reports 2018 Financial Results
07/03/2019
- Full Year 2018 Net Revenues Increased by 49% to $31.6 Million and Fourth Quarter 2018 Net Revenues Increased by 20% to $9.1 Million - Fourth Quarter 2018 Highlights vs. Fourth Quarter 2017 Entered into a global [...]
T2 Biosystems Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
07/03/2019
Secured 14 New Instrument Contracts in the Fourth Quarter and 39 total New Instrument Contracts in 2018 that are expected to drive growth in Recurring Test Revenue Confirms Guidance of a Doubling of Revenue in 2019; [...]
Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives
07/03/2019
- Clinical trial results expected for AB-506, a potent capsid inhibitor, and AB-729, a subcutaneously administered RNAi agent targeting HBsAg - Ongoing analyses of AB-452, a novel orally-available RNA destabilizer, with [...]
Acer Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
07/03/2019
Acer continues to progress toward goals of commercializing EDSIVO™ and advancing pipeline NEWTON, Mass., March 07, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the [...]
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2019
07/03/2019
RANCHO CUCAMONGA, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its fourth quarter of 2018 ended December 31, 2018, after [...]
Verrica Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
WEST CHESTER, Pa., March 07, 2019 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a medical dermatology company committed to the development and commercialization of novel treatments that [...]
Celldex Provides Corporate Update and Reports Full Year 2018 Results
07/03/2019
HAMPTON, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the fourth quarter and year ended December 31, 2018. The Company will host [...]
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Highlights
07/03/2019
Sunesis to Host Conference Call Today at 4:30 PM Eastern Time SOUTH SAN FRANCISCO, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the fourth [...]
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2018
07/03/2019
CAMBRIDGE, Mass., March 07, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]

Pages